Inducible nitric oxide synthase gene (NOS2A) haplotypes and the outcome of hepatitis C virus infection
Open Access
- 26 February 2004
- journal article
- research article
- Published by Springer Nature in Genes & Immunity
- Vol. 5 (3) , 183-187
- https://doi.org/10.1038/sj.gene.6364054
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Haplotypic relationship between SNP and microsatellite markers at the NOS2A locus in two populationsGenes & Immunity, 2003
- Peginterferon Alfa-2a in Patients with Chronic Hepatitis CNew England Journal of Medicine, 2000
- Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis CNew England Journal of Medicine, 1998
- Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virusPublished by Elsevier ,1998
- NO Inhibitions: Antimicrobial Properties of Nitric OxideClinical Infectious Diseases, 1995
- Altered immune responses in mice lacking inducible nitric oxide synthaseNature, 1995
- Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthaseCell, 1995
- Induction of nitric oxide synthase protects against malaria in mice exposed to irradiated Plasmodium berghei infected mosquitoes: involvement of interferon gamma and CD8+ T cells.The Journal of Experimental Medicine, 1994
- Recombinant Interferon Alfa Therapy for Chronic Hepatitis CNew England Journal of Medicine, 1989
- Treatment of Chronic Hepatitis C with Recombinant Interferon AlfaNew England Journal of Medicine, 1989